Evrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated to date
The covid health center will be managed and administered by the district administration of Ballari
Merck is studying the Complete Response Letter and it is not related to the safety of gefapixant
Omicron patients below 60 with no comorbidities can start treatment with paracetamol
It is the first monoclonal antibody drug for use in any animal species
The study will be published on the pre-print server, medRXiv, shortly
In addition to its favourable activity profile, IBIO123 is formulated for administration by inhalation providing an efficient, rapid and non-invasive delivery method into the lungs via the respiratory tract
Health experts of the country have pointed out that the benefits of the drug outweigh the potential risks it may have in the case of high-risk patients
Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma
Six months after receipt of the second Covaxin dose, participants received booster dose of the same. The trial demonstrated long-term safety with no serious events
Subscribe To Our Newsletter & Stay Updated
